Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report)'s share price gapped down prior to trading on Monday . The stock had previously closed at $17.18, but opened at $16.03. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.06, with a volume of 8,957 shares trading hands.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on TLX shares. UBS Group increased their price target on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a "buy" rating in a research note on Monday, January 27th. William Blair reaffirmed an "outperform" rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research report on Wednesday, March 12th.
Check Out Our Latest Stock Analysis on TLX
Telix Pharmaceuticals Limited American Depositary Shares Trading Down 5.6%
The company has a 50-day moving average of $17.11.
Institutional Investors Weigh In On Telix Pharmaceuticals Limited American Depositary Shares
An institutional investor recently bought a new position in Telix Pharmaceuticals Limited American Depositary Shares stock. Private Advisor Group LLC bought a new position in shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 10,140 shares of the company's stock, valued at approximately $170,000.
Telix Pharmaceuticals Limited American Depositary Shares Company Profile
(
Get Free Report)
Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
